| R100715Q |
Aciclovir syrup and injection |
Drugs, Metabolites |
Nicotinic acid
Aciclovir
(Acyclovir) |
YMC-Triart C18 |
TA12S05-1546WT |
| H140429A |
Aciclovir (JP 16th; Related substances, Assay) |
Drugs, Metabolites |
Aciclovir
Guanine |
Meteoric Core C18 BIO |
CAW16SQ7-1046PT |
| R100720B |
Aciclovir for syrup |
Drugs, Metabolites |
Aciclovir
(Acyclovir)
p-Hydroxybenzoic acid |
YMC-Triart C18 |
TA12S05-2546WT |
| J010528C |
Acyclovir |
Drugs, Metabolites |
Acyclovir
(Aciclovir) |
YMC-Pack Pro C18 |
AS12S05-1546WT |
| H3200706F |
Econazole |
Drugs, Metabolites
Optical isomers |
Econazole |
CHIRAL ART Cellulose-SZ |
KSZ99S05-1546WT |
| R101005O |
Butenafine hydrochloride |
Drugs, Metabolites |
Butenafine hydrochloride |
YMC-Triart C18 |
TA12S03-1503WT |
| R100830A |
Butenafine hydrochloride solution and spray and cream |
Drugs, Metabolites |
Diphenyl (I.S.)
Butenafine hydrochloride |
YMC-Pack Pro C8 |
OS12S03-0503WT |
| A110708A |
Terbinafine hydrochloride |
Drugs, Metabolites |
Terbinafine hydrochloride |
YMC-Pack Pro C18 RS |
RS08S05-1503WT |
| A110721C |
Terbinafine hydrochloride solution、spray and cream |
Drugs, Metabolites |
p-Terphenyl
Terbinafine hydrochloride |
YMC-Pack ODS-A |
AA30S05-R504WT |
| V121023A |
Levocarnitine injection(L-Carnitine injection) |
Drugs, Metabolites |
Levocarnitine chloride(L-Carnitine chloride)
Levocarnitine impurity A |
YMC-Triart Diol-HILIC |
TDH12S05-1546WT |
| F000629A |
Carnitine chloride |
Drugs, Metabolites |
Carnitine chloride
L-Histidine hydrochloride |
Hydrosphere C18 |
HS12S05-1546WT |
| F000817A |
Catecholamines |
Drugs, Metabolites |
Norepinephrine hydrochloride
Epinephrine
3,4-Dihydroxyphenylalanine (DOPA)
Dopamine hydrochloride
4-Hydroxy-3-methoxymandelic acid
3-Methoxytyramine hydrochloride
4-Hydroxy-3-methoxyphenylglycol
3,4-Dihydroxyphenylacetic acid
Homovanillic acid |
Hydrosphere C18 |
HS12S05-1546WT |
| F130425D |
Simultaneous analysis of catecholamines,serotonin, and their precursors and metabolites |
Drugs, Metabolites |
Noradrenaline hydrochloride (NA) (Norepinephrine hydrochloride)
3,4-Dihydroxymandelic acid (DOMA)
3,4-Dihydroxyphenylalanine (DOPA)
Tyrosine (Tyr)
Adrenaline hydrochloride (A) (Epinephrine hydrochloride)
Dopamine hydrochloride (DA)
Vanillylmandelic acid (VMA)
3-Methoxy-4-hydroxyphenylglycol (MHPG)
3,4-Dihydroxyphenylacetic acid (DOPAC)
3-Methoxytyramine hydrochloride (3MT)
Serotonin hydrochloride (5-Hydroxytryptamine hydrochloride,5-HT)
Tryptophan (Typ)
5-Hydroxyindoleacetic acid (5HIAA)
Homovanillic acid (HVA) |
YMC-Triart PFP |
TPF12S03-1503WT |
| F070906B |
Xanthine oxidase inhibitor and its metabolites - method transfer to ultra-fast LC |
Drugs, Metabolites |
Uric acid
Hypoxanthine
Xanthine
Oxipurinol
Allopurinol |
YMC-UltraHT Hydrosphere C18 |
HS12S02-0502WT |
| F070906B |
Xanthine oxidase inhibitor and its metabolites - method transfer to ultra-fast LC |
Drugs, Metabolites |
Uric acid
Hypoxanthine
Xanthine
Oxipurinol
Allopurinol |
Hydrosphere C18 |
HS12S05-1546WT |
| F070906A |
Xanthine oxidase inhibitor and its metabolites in human serum |
Drugs, Metabolites |
Uric acid
Hypoxanthine
Xanthine
Oxipurinol
Allopurinol |
YMC-UltraHT Hydrosphere C18 |
HS12S02-0502WT |
| S930728J |
Xanthine oxidase inhibitor and related compounds |
Drugs, Metabolites |
Uric acid
Hypoxanthine
Xanthine
Oxipurinol
Allopurinol |
J'sphere ODS-M80 |
JM08S04-1546WT |
| S930729B |
Xanthine oxidase inhibitor and related compounds |
Drugs, Metabolites |
Uric acid
Hypoxanthine
Xanthine
Oxipurinol
Allopurinol |
J'sphere ODS-L80 |
JL08S04-1546WT |
| E211026A |
8-OHdG, an oxidative stress marker and related compounds |
Drugs, Metabolites |
7-Methylguanine (m7Gua)
8-Hydroxy-2’-deoxyguanosine (8-OHdG)
(-)-Nicotine
(-)-Cotinine
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) |
YMC-Triart C18 |
TA12SP9-05Q1PT |
| E211130A |
8-OHdG, an oxidative stress marker and related compounds |
Drugs, Metabolites |
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL)
(-)-Cotinine
(-)-Nicotine
7-Methylguanine (m7Gua)
8-Hydroxy-2’-deoxyguanosine (8-OHdG) |
YMC-Triart Diol-HILIC |
TDH12SP9-10Q1PT |
